Literature DB >> 8425772

Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs.

J R Masters1, E J Osborne, M C Walker, C N Parris.   

Abstract

Metastatic testis tumours, in contrast to most other types of cancer, can be cured by drugs. To investigate which classes of chemotherapeutic drug are differentially toxic to testis-tumour cells, we compared the in vitro dose-response curves of 5 human testis and 5 bladder-cancer cell lines to 12 compounds. The testis cells were hypersensitive to drugs that interact directly with DNA (m-amsa, bleomycin, cisplatin, doxorubicin, methylnitrosourea, mitozolomide, etoposide, mitomycin-C), but little or no difference between the 2 cell types was seen following exposure to drugs whose mechanisms of action do not involve direct interaction with DNA (methotrexate, 5-fluorouracil, colchicine, vinblastine). We conclude that testis tumour cells are either less tolerant of, or have a reduced capacity to repair, DNA damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425772     DOI: 10.1002/ijc.2910530228

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Binding interaction of HMGB4 with cisplatin-modified DNA.

Authors:  Semi Park; Stephen J Lippard
Journal:  Biochemistry       Date:  2012-08-17       Impact factor: 3.162

2.  p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.

Authors:  Matthias Gutekunst; Moshe Oren; Andrea Weilbacher; Michael A Dengler; Christiane Markwardt; Jürgen Thomale; Walter E Aulitzky; Heiko van der Kuip
Journal:  PLoS One       Date:  2011-04-21       Impact factor: 3.240

3.  Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.

Authors:  Svetlana Usanova; Andrea Piée-Staffa; Ulrike Sied; Jürgen Thomale; Astrid Schneider; Bernd Kaina; Beate Köberle
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

4.  Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat.

Authors:  E H Richards; J A Hickman; J R Masters
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

5.  Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.

Authors:  H Burger; K Nooter; A W Boersma; C J Kortland; G Stoter
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

6.  Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Authors:  M W Sark; H Timmer-Bosscha; C Meijer; D R Uges; W J Sluiter; W H Peters; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

7.  Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide.

Authors:  M F Pera; B Köberle; J R Masters
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

8.  Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.

Authors:  F Selle; J Gligorov; S Richard; A Khalil; I Alexandre; D Avenin; S Provent; D G Soares; J P Lotz
Journal:  Braz J Med Biol Res       Date:  2014-11-04       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.